Matthew S. Metcalfe

First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials

Harpreet Wasan, Navesh Sharma, Volker Heinemann et al. · The Lancet Oncology · 2017 · 398 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Preoperative Neutrophil‐to‐Lymphocyte Ratio (NLR) is Associated with Reduced Disease‐free Survival Following Curative Resection of Pancreatic Adenocarcinoma

Giuseppe Garcea, Nikhil Ladwa, Christopher P. Neal et al. · World Journal of Surgery · 2011 · 198 citations

Medicine, Hematology, Oncology +13

Curcumin inhibits cancer stem cell phenotypes in ex vivo models of colorectal liver metastases, and is clinically safe and tolerable in combination with FOLFOX chemotherapy

Mark I. James, Chinenye Iwuji, Glen R.B. Irving et al. · Cancer Letters · 2015 · 182 citations · Full text

Medicine, Oncology, Pharmacology +14

A psychometric evaluation of the Hospital Anxiety and Depression Scale in patients diagnosed with end‐stage renal disease

Colin R. Martin, Alison Tweed, Matthew S. Metcalfe · British Journal of Clinical Psychology · 2004 · 99 citations

Medicine, Internal Medicine, Nephrology +17

Case-matched comparison of long-term results of non-heart beating and heart-beating donor renal transplants

Adam D. Barlow, Matthew S. Metcalfe, Y Johari et al. · British journal of surgery · 2009 · 98 citations · Full text

Medicine, Nephrology, Surgery +9